Medication errors can harm individual patients. But when errors also undermine trust in public health programmes, serious problems can ripple across entire communities.

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?

With low reporting of medication errors in Africa, understanding the scale of the problem and the reasons behind it should help in efforts to improve the situation.

Medication errors account for the bulk of adverse events to medicines. How do they occur, how do we ensure they are reported if they do occur, and how may we prevent them?

Medication errors are a key pharmacovigilance issue, especially as patients transition between secondary and primary care as they readjust to life outside of hospital.

Compared to the general population, older adults are more at risk of experiencing adverse drug reactions. Why is this the case, and what does this mean for pharmacovigilance?